
MHRA ramps up assessment capacity for in-vitro diagnostic devices
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has extended the designation of UL International UK Ltd as an Approved Body.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has extended the designation of UL International UK Ltd as an Approved Body.
A fund of over £113 million has been announced today (28 November 2022) to develop innovative medicines and diagnostics for cancer, obesity, mental health and addiction in the UK population.